Genzyme Corp. opened its new Science Center in Framingham, MA. The facility serves as a central site for early stage research to discover new treatments for diseases such as Parkinson's, cancer, and heart disease. The Science Center has received a Gold certification under the U.S. Green Building Council's LEED (Leadership in Energy and Environmental Design) Green Building Rating System. It's one of 10 labs to receive this rating.
"Genzyme exists to innovate, and the Science Center reflects this purpose," stated Henri A. Termeer, Genzyme's chairman and chief executive officer. "The work done at this facility will ensure that we can continue to bring forward therapies to significantly improve patients' lives and will help support the company's long-term growth. I am so proud of our scientists who discover and make possible life-saving medicines."
Researchers at the Science Center focus on areas including genetic diseases, cancer, immune diseases, kidney disease, cardiovascular disease, endocrinology and neurological disorders, and utilize a range of technologies, such as proteins, antibodies, cell therapy and gene therapy.
Magazine
